查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417204

中风管理市场报告：2030 年趋势、预测与竞争分析

Stroke Management Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

卒中管理的趋势和预测

预计到 2030 年，全球卒中管理市场将达到 651.4 亿美元，2024 年至 2030 年复合年增长率为 8.5%。该市场的主要驱动力是人口老化的加剧、心臟疾病和高血压患者数量的增加以及中风诊断方法的技术进步。全球中风管理市场的未来看起来充满希望，缺血性中风和出血性中风市场充满机会。

中风管理市场洞察

Lucintel 预计，由于大众对中风疾病早期诊断的了解增加，导致中风诊断数量增加，诊断在预测期内将出现最高增长。

由于医疗费用增加和可支配收入增加，亚太地区预计在预测期内将出现最高增长。

常问问题

Q.1 中风管理的市场规模有多大？

A1. 到 2030 年，全球卒中管理市场预计将达到 651.4 亿美元。

Q.2 中风管理市场的成长预测为何：

A2. 2024年至2030年，全球中风管理市场预计复合年增长率为8.5%。

Q.3 影响中风管理市场成长的关键因素有哪些：

A3. 该市场的主要驱动力是人口老化、心臟疾病和高血压患者数量的增加以及中风诊断方法的技术进步。

Q4.市场的主要细分市场是：

A4. 中风管理市场的未来前景广阔，缺血性中风和出血性中风市场充满机会。

Q5.市场的主要企业是：

A5.以下是主要的中风管理公司。

  • B Braun Melsungen
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • Glaxosmithkline

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于公众对中风疾病早期诊断的了解增加，导致中风诊断数量增加，诊断在预测期内将出现最高增长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于医疗保健成本上升和可支配收入增加，亚太地区预计在预测期内将出现最高增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球中风管理市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球中风管理市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球中风管理市场
    • 诊断
    • 疗法
    • 软体
  • 按应用分類的全球中风管理市场
    • 缺血性中风
    • 出血性中风

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球中风管理市场
  • 北美中风管理市场
  • 欧洲中风管理市场
  • 亚太地区中风管理市场
  • 其他地区的卒中管理市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球中风管理市场成长机会
    • 全球中风管理市场成长机会（按应用）
    • 按地区分類的全球中风管理市场成长机会
  • 全球卒中管理市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球中风管理市场的产能扩张
    • 全球卒中管理市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • B Braun
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • NeuraSignal
简介目录

Stroke Management Trends and Forecast

The future of the global stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets. The global stroke management market is expected to reach an estimated $65.14 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

A more than 150-page report is developed to help in your business decisions.

Stroke Management by Segment

The study includes a forecast for the global stroke management by type, application, and region.

Stroke Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Therapeutics
  • Software

Stroke Management Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Ischemic Stroke
  • Hemorrhagic Stroke

Stroke Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stroke Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stroke management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stroke management companies profiled in this report include-

  • B Braun
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • Neurasignal

Stroke Management Market Insights

Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Features of the Global Stroke Management Market

Market Size Estimates: Stroke management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stroke management market size by type, application, and region in terms of value ($B).

Regional Analysis: Stroke management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the stroke management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stroke management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stroke management market size?

Answer: The global stroke management market is expected to reach an estimated $65.14 billion by 2030.

Q.2 What is the growth forecast for stroke management market?

Answer: The global stroke management market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stroke management market?

Answer: The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

Q4. What are the major segments for stroke management market?

Answer: The future of the stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets.

Q5. Who are the key stroke management market companies?

Answer: Some of the key stroke management companies are as follows.

  • B Braun Melsungen
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • Glaxosmithkline

Q6. Which stroke management market segment will be the largest in future?

Answer: Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

Q7. In stroke management market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stroke management market by type (diagnostics and therapeutics), application (ischemic stroke and hemorrhagic stroke), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stroke Management Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stroke Management Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stroke Management Market by Type
    • 3.3.1: Diagnostics
    • 3.3.2: Therapeutics
    • 3.3.3: Software
  • 3.4: Global Stroke Management Market by Application
    • 3.4.1: Ischemic Stroke
    • 3.4.2: Hemorrhagic Stroke

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stroke Management Market by Region
  • 4.2: North American Stroke Management Market
    • 4.2.2: North American Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
  • 4.3: European Stroke Management Market
    • 4.3.1: European Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
    • 4.3.2: European Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
  • 4.4: APAC Stroke Management Market
    • 4.4.1: APAC Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
    • 4.4.2: APAC Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
  • 4.5: ROW Stroke Management Market
    • 4.5.1: ROW Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
    • 4.5.2: ROW Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stroke Management Market by Type
    • 6.1.2: Growth Opportunities for the Global Stroke Management Market by Application
    • 6.1.3: Growth Opportunities for the Global Stroke Management Market by Region
  • 6.2: Emerging Trends in the Global Stroke Management Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stroke Management Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stroke Management Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: B Braun
  • 7.2: Cardinal Health
  • 7.3: Medtronic
  • 7.4: Bristol Myers Squibb
  • 7.5: Boston Scientific Corporation
  • 7.6: Abbott Laboratories
  • 7.7: General Electric Company
  • 7.8: Merck
  • 7.9: Siemens
  • 7.10: NeuraSignal